As of 2025-12-25, the EV/EBITDA ratio of STAAR Surgical Co (STAA) is -18.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STAA's latest enterprise value is 999.20 mil USD. STAA's TTM EBITDA according to its financial statements is -53.35 mil USD. Dividing these 2 quantities gives us the above STAA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 14.6x | 13.8x |
| Forward P/E multiples | 13.2x - 17.7x | 15.9x |
| Fair Price | (10.68) - 7.87 | (1.91) |
| Upside | -145.2% - -66.7% | -108.1% |
| Date | EV/EBITDA |
| 2025-12-23 | -19.01 |
| 2025-12-22 | -19.26 |
| 2025-12-19 | -20.14 |
| 2025-12-18 | -19.09 |
| 2025-12-17 | -20.84 |
| 2025-12-16 | -19.82 |
| 2025-12-15 | -18.66 |
| 2025-12-12 | -19.20 |
| 2025-12-11 | -19.71 |
| 2025-12-10 | -19.07 |
| 2025-12-09 | -20.37 |
| 2025-12-08 | -18.65 |
| 2025-12-05 | -20.36 |
| 2025-12-04 | -21.50 |
| 2025-12-03 | -21.28 |
| 2025-12-02 | -20.87 |
| 2025-12-01 | -20.86 |
| 2025-11-28 | -21.44 |
| 2025-11-26 | -20.97 |
| 2025-11-25 | -21.14 |
| 2025-11-24 | -21.44 |
| 2025-11-21 | -22.80 |
| 2025-11-20 | -22.20 |
| 2025-11-19 | -21.36 |
| 2025-11-18 | -20.63 |
| 2025-11-17 | -21.41 |
| 2025-11-14 | -21.24 |
| 2025-11-13 | -20.97 |
| 2025-11-12 | -20.80 |
| 2025-11-11 | -22.25 |
| 2025-11-10 | -22.25 |
| 2025-11-07 | -21.45 |
| 2025-11-06 | -21.53 |
| 2025-11-05 | -20.24 |
| 2025-11-04 | -20.27 |
| 2025-11-03 | -20.25 |
| 2025-10-31 | -20.82 |
| 2025-10-30 | -21.43 |
| 2025-10-29 | -21.49 |
| 2025-10-28 | -22.02 |
| 2025-10-27 | -22.60 |
| 2025-10-24 | -21.19 |
| 2025-10-23 | -21.84 |
| 2025-10-22 | -19.91 |
| 2025-10-21 | -21.58 |
| 2025-10-20 | -20.31 |
| 2025-10-17 | -20.04 |
| 2025-10-16 | -19.32 |
| 2025-10-15 | -20.75 |
| 2025-10-14 | -21.96 |